Evidence map›Paper›PMID 35249528›Full record

Trial reportBMC medical research methodology2022

Documenting patients' and providers' preferences when proposing a randomized controlled trial: a qualitative exploration.

Devesh Oberoi, Cynthia Kwok, Yong Li, Cindy Railton, Susan Horsman, Kathleen Reynolds, Anil A Joy, Karen Marie King, Sasha Michelle Lupichuk, Michael Speca and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medical research methodology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Devesh OberoiDivision of Psychosocial Oncology, Department of Oncology, Faculty of Medicine, Cumming School of Medicine, Department of Psychosocial Resources, Tom Baker Cancer Centre, Holy Cross Site, 2202 2nd St. SW, AB, T2S 3C1, Calgary, Canada. devesh.oberoi@albertahealthservices.ca.
Cynthia KwokMedical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.
Yong LiMedical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.
Cindy RailtonHoly Cross Centre CancerControl Alberta, Alberta Health Services, AB, T2S 3C3, Calgary, Canada.
Susan HorsmanCross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.
Kathleen ReynoldsLong Term Survivors Clinic, Alberta Children's Hospital, 2888 Shaganappi Trail NW, AB, T3B 6AB, Calgary, Canada.
Anil A JoyCross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.
Karen Marie KingCross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.
Sasha Michelle LupichukMedical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.
Michael SpecaMedical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.
Nicole Culos-ReedDepartment of Kinesiology, University of Calgary, 2500 University Dr. NW, T2N 1N4, Calgary, AB, Canada.
Linda E CarlsonDepartment of Oncology, University of Calgary, 2202 2nd St. SW, T2S 3C1, Calgary, AB, Canada.
Janine Giese-DavisDepartment of Oncology, University of Calgary, 2202 2nd St. SW, T2S 3C1, Calgary, AB, Canada.
University of Calgary · CAAlberta Children's Hospital · CAAlberta Health Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith advances in cancer diagnosis and treatment, women with early-stage breast cancer (ESBC) are living longer, increasing the number of patients receiving post-treatment follow-up care. Best-practice survivorship models recommend transitioning ESBC patients from oncology-provider (OP) care to community-based care. While developing materials for a future randomized controlled trial (RCT) to test the feasibility of a nurse-led Telephone Survivorship Clinic (TSC) for a smooth transition of ESBC survivors to follow-up care, we explored patients' and OPs' reactions to several of our proposed methods.

methodsWe used a qualitative study design with thematic analysis and a two-pronged approach. We interviewed OPs, seeking feedback on ways to recruit their ESBC patients for the trial, and ESBC patients, seeking input on a questionnaire package assessing outcomes and processes in the trial.

resultsOPs identified facilitators and barriers and offered suggestions for study design and recruitment process improvement. Facilitators included the novelty and utility of the study and simplicity of methods; barriers included lack of coordination between treating and discharging clinicians, time constraints, language barriers, motivation, and using a paper-based referral letter. OPs suggested using a combination of electronic and paper referral letters and supporting clinicians to help with recruitment. Patient advisors reported satisfaction with the content and length of the assessment package. However, they questioned the relevance of some questions (childhood trauma) while adding questions about trust in physicians and proximity to primary-care providers.

conclusionsOPs and patient advisors rated our methods for the proposed trial highly for their simplicity and relevance then suggested changes. These findings document processes that could be effective for cancer-patient recruitment in survivorship clinical trials.

Indexed as

Breast NeoplasmsSurvivorsAftercareFemaleHumansMedical OncologySurveys and QuestionnairesBreast cancerCancer care coordinationCancer survivorsOncology nurseTelephone survivorship clinicTransition of care

Identifiers

PMID35249528
PMCPMC8898414
OpenAlexW4220660709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.